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Patient A received his transplant in July 2001. Cardiac 
biopsies showed no rejection on a stable immuno- 
suppressive regimen of mycophenolate, tacrolimus and 
prednisone. Renal status was stable with a creatinine 
of 1.4mg/dl and CMV prophylaxis with ganciclovir 
and valganciclovir was used. PCP prophylaxis with 
pentamidine was given. In mid October a BAL culture 
grew Aspergillus and Nocardia. Treatment was begun 
with tmp/smz, imipenem, and caspofungin plus lipid 
formulation amphotericin B. Ventilatory support and 
chest tube drainage were needed, and CT imaging showed 
cranial involvement. The patient died in December. 
Patient B received his heart transplant in 1997. 
Surveillance heart biopsies showed no evidence of 
rejection and renal function was stable with a creatinine 
around 2mg/dl. PCP prophylaxis with tmp/smz was given 
for two years until July 1999. The patient developed 
persistent pleural effusions that reoccurred in spite of 
repeated drainage. Specimens from surgical decortication 
and evacuation of the effusions grew Nocardia that was 
treated with IV tmp/smz for one month. An MRI did not 
show any intracranial lesions. Outpatient treatment with 
oral tmp/smz was continued. 
The third patient received his transplant in February 
2001. Myocardial biopsies confirmed grade I and grade 
III rejection 2 months and 7 months post transplantation 
respectively. In the second instance a short-term increase 
in immunosuppression was given. The patient also 
received lamivudine and ganciclovir because the donor 
was hepatitis B core antibody positive and had positive 
CMV serology. Prophylaxis with tmp/smz three times 
weekly was begun in March. Renal function was stable. 
Subsequent to respiratory complaints a CT of the chest 
was obtained in October and showed a significant pul- 
monary lesion. Bronchoscopy specimens grew Nocardia 
and Aspergillus. Imaging of the head did not reveal any 
cranial involvement. IV treatment with caspofungin, 
imipenem and cefotaxime continued through the middle 
of December with improvement of the pulmonary 
lesions on repeat CT. The patient was discharged on 
outpatient oral therapy with tmp/smz and itraconazole. 
This uncanny cluster of nocardia infections in heart 
transplant patients exhibits the importance of consider- 
ing Nocardia as opportunistic pathogens in transplant 
patients even if tmp/smz prophylaxis has been given. 
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Introduction: Cytomegalovirus reactivation is common 
and carries serious morbidity and high mortality in 
patients undergoing allogeneic marrow transplantation, 
especially in recipients of marrow grafts from CMV- 
seropositive donors. The impact of early viral reactivation 
on response to antiviral treatment is uncertain. 
Methods: Seven recipients of two and greater than two 
HLA-antigen mismatched, related marrow transplant- 
ation during 1999-2000 were evaluated prospectively for 
CMV viremia by real-time PCR technique (Speciality 
Laboratories, Santa Monica, CA) performed on post- 
transplantation day + 1, and than weekly. All values are 
given in median+standard deviation. 
Results: Five had refractory or recurrent acute myelo- 
genous leukemia (AML), and two with acute lympho- 
cytic leukemia (ALL). Four received 3 HLA-antigen 
mismatched marrow grafts from a related donor. Three 
had evidence of CMV in the peripheral blood on 12+5 
days (age 17+11 years), whereas four (age 26+24 years) 
had evidence of reactivation on 30-t 4 days following 
BMT. In the sub-group with early reactivation (day 
12+5), median CMV viral load was 258+91 copies/ml, 
and 1291+4220 copies/ml in the remaining four (P~0.5). 
Four patients had clinical and virological failure to initial 
therapy with ganciclovir (5 mg/kg every 12 hours). 
Among these, two (2/3; 66.7%) patients had evidence of 
early CMV reactivation and the other two (2/4; 50%) 
had evidence of reactivation around post transplant day 
+30 (P>O.5). 
Conclusions: Cytomegalovirus reactivation during the 
first two weeks of transplantation was associated with 
low-grade viremia. We did not observed a significant 
association with early CMV reactivation and failure to 
initial ganciclovir therapy in patients following high-risk 
allogeneic marrow transplantation. 
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Background and objective:. The present study was 
undertaken to evaluate the therapeutic effects of 
pancreatic beta-cells in diabetic animals immunized by 
Escherichi coli vaccine. 
Study design/ materials and methods: Ten days after 
streptozocin injection (60 mg/ kg), diabetic rats received 
intraperitoneal injection of pancreatic beta-cells 
(5.7~10~ cells/rat). Twelve days later both the diabetic 
and healthy animals were immunized by oral route with 
enteroinvasive E. coli (0136 serotype) acetone-killed 
vaccine. Twenty-one days after beta-cells transplantation 
lamina propria and Peyer’s patches lymphoid T cells 
were obtained from the intestine. 
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Main results: Intraperitoneal implantation of purified 
beta-cells improved the diabetic state within 8-10 days. 
The metabolic parameters were stable within 4-5 weeks 
after islet transplantation in fifteen of twenty-one 
recipients (71.4%). Stimulation with PHA at 21 days 
post beta- cells grafts produced a marked increase in 3H- 
Thymidine incorporation in lamina propria and Peyer’s 
patches lymphoid T cells. 
Conclusions: (1) These results demonstrated normal- 
ization of metabolic and immunologic parameters 
in diabetic rats which received associated therapy 
(pancreatic beta-cells and E. coli vaccine) and (2) beta- 
cells stimulated the immune response to Escherichia coli 
vaccine. 
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Allogeneic stem cell transplantation from donors other 
than HLA-matched siblings results in a high risk of post- 
transplant infections because of the risk of graft-versus- 
host disease (GVHD) with an unmanipulated graft, or 
delayed immune reconstitution following T cell-depletion 
(TCD). We compared infectious outcomes in the first 
yr post-transplant (tx) in 28 consecutive recipients of 
stringently TCD blood hematopoeitic progenitor cell 
(HPC) grafts from haploidentical family donors (HD), 
and 28 consecutive recipients of unmanipulated grafts 
from matched or 1 Ag mismatched unrelated donors 
(URD). Included are pts (excluding CML-CPl) trans- 
planted at our center between 6198 and 12/01 after 
myeloablative conditioning. HD pts received pre-tx ATG, 
and no scheduled post-tx immunosuppression. URD pts 
received tacrolimus and methotrexate for GVHD 
prophylaxis. Median CD3-t cell dose/kg was 3.6 logs 
lower in the HD vs URD grafts (p<O.OOOl). Median age 
was 31y (21-56) for HD and 43y (18-51) for URD pts. 
15 HD and 17 URD pts were in relapse at time of 
transplant. Acute and/or chronic extensive GVHD 
occurred in 80% of evaluable URD pts vs 15% of HD 
pts (p<O.OOl). Bacteremias were the most common in- 
fections, occurring at similar frequencies in the two groups. 
Polymicrobial bacteremias occurred exclusively in URD 
patients (n=7; p=O.O09). Proven/probable invasive 
fungal infections (IFI) occurred in 23% of HD pts, and 
12% of URD pts (p =NS). Frequency and timing of 
CMV reactivation (by PCR), late CMV reactivation (>d 
loo), and CMV disease were similar in the two groups. 
EBV-associated PTLD was unique to HD pts (n=3), 
and drug-resistant HSV disease was also more common 
after HD tx. Infection related deaths (censored at 1 yr) 
in HD pts included bacterial sepsis (3),Aspergillosis (3) 
parainfluenza pneumonia (2) PCP (1) other pneumonia 
(l), amebic encephalitis (1) toxoplasmosis (1) EBV- 
PTLD (l), and acalculous cholecystitis (1). Infectious 
deaths in URD pts resulted from IF1 (3) bacterial sepsis 
(2), CMV pneumonia (1) aspiration pneumonia (1) and 
acalculous cholecystitis (1). 
Infection 
related Relapse 
Regimen- 
related 
(toxic) Unknown 
HD 
URD 
n=14 n=9 
n=8 n=4 
(p=O.l) (p=O.l) 
n=l 
n=7 
(p=O.O2) 
n=2 
n=O 
(p=O.O9) 
Infections are the most common cause of death in these 
pts. The trend toward higher risk of infectious death 
following TCD HD vs unmanipulated URD transplants 
was not statistically significant, although the spectrum of 
infections was different. Strategies aimed at enhancing 
immune reconstitution without stimulating GVHD are 
needed to reduce the risks of infection and relapse after 
stringently TCD alternative donor transplantation. 
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The spectrum of Aspergillus induced human pulmonary 
afflictions vary greatly from apparently harmless 
colonization to a fulminant and rapidly fatal disease. 
Invasive aspergillosis (IA) is a disease that occurs 
primarily in severely immunocompromised patients, 
clinical diagnosis in whom is often difficult and missed, 
adding to the severity of the outcome. 
Aims and objectives: To study the occurrence of IA 
in cases of chronic bronchopulmonary disorders with 
locally and/ or systemically immunocompromised con- 
ditions and correlate the role of clinical and radiological 
parameters of these patients with a battery of laboratory 
investigations in the early diagnosis and management. 
Materials and methods: Thirty-four patients of chronic 
bronchopulmonary disorders with suspected aspergillosis 
and underlying immunocompromised state were studied. 
Thorough clinical, hematological and radiological exam- 
inations were carried out. Sputum, bronchial aspirate/ 
BAL and serum samples were collected. Microscopy and 
culture for Aspergillus spp in addition to detection of 
specific anti-A. fumigatus IgG and IgE by ELISA and 
skin sensitivity tests against Aspergillus spp were per- 
formed. 
Results: Out of 34 cases studied, 7 were diagnosed as IA: 
2 as highly probable and 5 as probable cases. IA was 
found to be most common in ~20 and ~60 years of age 
